Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: An update

Journal of Autoimmune Diseases

Volumn 2, Issue , 2005, Pages

  Bresson, Damien ^a,b   Rebuffat, Sandra A ^a   Péraldi Roux, Sylvie ^a  

^a CNRS   (France)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY;

ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; DISEASE COURSE; ENZYME STRUCTURE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE SYSTEM; NONHUMAN; REVIEW; THYROID DISEASE;

EID: 19944379819     PISSN: 17402557     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-2-2     Document Type: Review

References (46)

1. Nagayama Y, Rapoport B: The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol 1992, 6:145-56.
2. Rapoport B, McLachlan SM: Thyroid autoimmunity. J Clin Invest 2001, 108:1253-9.
3. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A: Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990, 71:661-9.
4. Banga JP, Barnett PS, McGregor AM: Immunological and molecular characteristics of the thyroid peroxidase autoantigen. Autoimmunity 1991, 8:335-43.
5. McLachlan SM, Rapoport B: Autoimmune response to the thyroid in humans: thyroid peroxidase - the common autoantigenic denominator. Int Rev Immunol 2000, 19:587-618.
6. Parkes AB, Othman S, Hall R, John R, Richards CJ, Lazarus JH: The role of complement in the pathogenesis of postpartum thyroiditis. J Clin Endocrinol Metab 1994, 79:395-400.
7. Wadeleux P, Winand-Devigne J, Ruf J, Carayon P, Winand R: Cytotoxic assay of circulating thyroid peroxidase antibodies. Autoimmunity 1989, 4:247-54.
8. Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A: Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 1993, 77:1700-5.
9. Guo J, Jaume JC, Rapoport B, McLachlan SM: Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J Clin Endocrinol Metab 1997, 82:925-31.
10. Metcalfe R, Jordan N, Watson P, Gullu S, Wiltshire M, Crisp M, Evans C, Weetman A, Ludgate M: Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab 2002, 87:1754-61.
11. Bogner U, Hegedus L, Hansen JM, Finke R, Schleusener H: Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis. Eur J Endocrinol 1995, 132:69-74.
12. Rodien P, Madec AM, Ruf J, Rajas F, Bornet H, Carayon P, Orgiazzi J: Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 1996, 81:2595-600.
13. Guo J, Quaratino S, Jaume JC, Costante G, Londei M, McLachlan SM, Rapoport B: Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by a recombinant human autoantibody Fab converted to IgE. J Immunol Methods 1996, 195:81-92.
14. Guo J, Wang Y, Rapoport B, McLachlan SM: Evidence for antigen presentation to sensitized T cells by thyroid peroxidase (TPO)-specific B cells in mice injected with fibroblasts co-expressing TPO and MHC class II. Clin Exp Immunol 2000, 119:38-46.
15. Hobby P, Gardas A, Radomski R, McGregor AM, Banga JP, Sutton BJ: Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology 2000, 141:2018-26.
16. Banga JP, Mahadevan D, Barton GJ, Sutton BJ, Saldanha JW, Odell E, McGregor AM: Prediction of domain organisation and secondary structure of thyroid peroxidase, a human autoantigen involved in destructive thyroiditis. FEBS Lett 1990, 266:133-41.
17. Estienne V, Duthoit C, Blanchin S, Montserret R, Durand-Gorde JM, Chartier M, Baty D, Carayon P, Ruf J: Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance. Int Immunol 2002, 14:359-66.
18. Estienne V, Blanchet C, Niccoli-Sire P, Duthoit C, Durand-Gorde JM, Geourjon C, Baty D, Carayon P, Ruf J: Molecular model, calcium sensitivity, and disease specificity of a conformational thyroperoxidase B-cell epitope. J Biol Chem 1999, 274:35313-7.
19. Gardas A, Sohi MK, Sutton BJ, McGregor AM, Banga JP: Purification and crystallisation of the autoantigen thyroid peroxidase from human Graves' thyroid tissue. Biochem Biophys Res Commun 1997, 234:366-70.
20. Hendry E, Taylor G, Ziemnicka K, Grennan Jones F, Furmaniak J, Rees Smith B: Recombinant human thyroid peroxidase expressed in insect cells is soluble at high concentrations and forms diffracting crystals. J Endocrinol 1999, 160:R13-5.
21. Gardas A, Lewartowska A, Sutton BJ, Pasieka Z, McGregor AM, Banga JP: Human thyroid peroxidase (TPO) isoforms, TPO-1 and TPO-2: analysis of protein expression in Graves' thyroid tissue. J Clin Endocrinol Metab 1997, 82:3752-7.
22. Ferrand M, Le Fourn V, Franc JL: Increasing diversity of human thyroperoxidase generated by alternative splicing. Characterized by molecular cloning of new transcripts with single- and multispliced mRNAs. J Biol Chem 2003, 278:3793-800.
23. Blanchin S, Estienne V, Guo J, Rapoport B, McLachlan SM, Carayon P, Ruf J: Human thyroperoxidase folds in one complex B-cell immunodominant region. Biochem Biophys Res Commun 2002, 295:1118-24.
24. Ruf J, Toubert ME, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P: Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 1989, 125:1211-8.
25. Chazenbalk GD, Costante G, Portolano S, McLachlan SM, Rapoport B: The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal antibody 47/c21 linear epitope. J Clin Endocrinol Metab 1993, 77:1715-8.
26. McLachlan SM, Rapoport B: Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: markers of the human thyroid autoimmune response. Clin Exp Immunol 1995, 101:200-6.
27. Portolano S, Chazenbalk GD, Seto P, Hutchison JS, Rapoport B, McLachlan SM: Recognition by recombinant autoimmune thyroid disease-derived Fab fragments of a dominant conformational epitope on human thyroid peroxidase. J Clin Invest 1992, 90:720-6.
28. Chapal N, Chardes T, Bresson D, Pugniere M, Mani JC, Pau B, Bouanani M, Peraldi-Roux S: Thyroid peroxidase autoantibodies obtained from random single chain FV libraries contain the same heavy/light chain combinations as occur in vivo. Endocrinology 2001, 142:4740-50.
29. Chapal N, Peraldi-Roux S, Bresson D, Pugniere M, Mani JC, Granier C, Baldet L, Guerrier B, Pau B, Bouanani M: Human anti-thyroid peroxidase single-chain fragment variable of Ig isolated from a combinatorial library assembled in-cell: insights into the in vivo situation. J Immunol 2000, 164:4162-9.
30. Guo J, McIntosh RS, Czarnocka B, Weetman AP, Rapoport B, McLachlan SM: Relationship between autoantibody epitopic recognition and immunoglobulin gene usage. Clin Exp Immunol 1998, 111:408-14.
31. Arscott PL, Koenig RJ, Kaplan MM, Glick GD, Baker JR Jr: Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase. J Biol Chem 1996, 271:4966-73.
32. Finke R, Seto P, Ruf J, Carayon P, Rapoport B: Determination at the molecular level of a B-cell epitope on thyroid peroxidase likely to be associated with autoimmune thyroid disease. J Clin Endocrinol Metab 1991, 73:919-21.
33. Bresson D, Cerutti M, Devauchelle G, Pugniere M, Roquet F, Bes C, Bossard C, Chardes T, Peraldi-Roux S: Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 2003, 278:9560-9.
34. Gora M, Gardas A, Wiktorowicz W, Hobby P, Watson PF, Weetman AP, Sutton BJ, Banga JP: Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis. Clin Exp Immunol 2004, 136:137-44.
35. Nishikawa T, Rapoport B, McLachlan SM: Exclusion of two major areas on thyroid peroxidase from the immunodominant region containing the conformational epitopes recognized by human autoantibodies. J Clin Endocrinol Metab 1994, 79:1648-54.
36. Estienne V, Duthoit C, Vinet L, Durand-Gorde JM, Carayon P, Ruf J: A conformational B-cell epitope on the C-terminal end of the extracellular part of human thyroid peroxidase. J Biol Chem 1998, 273:8056-62.
37. Grennan Jones F, Ziemnicka K, Sanders J, Wolstenholme A, Fiera R, Furmaniak J, Rees Smith B: Analysis of autoantibody epitopes on human thyroid peroxidase. Autoimmunity 1999, 30:157-69.
38. Xiong Z, Farilla L, Guo J, McLachlan S, Rapoport B: Does the autoantibody immunodominant region on thyroid peroxidase include amino acid residues 742-771? Thyroid 2001, 11:227-31.
39. Guo J, McLachlan SM, Rapoport B: Localization of the thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of the domains homologous to complement control protein and myeloperoxidase. J Biol Chem 2002, 277:40189-95.
40. Bresson D, Pugniere M, Roquet F, Rebuffat SA, B NG, Cerutti M, Guo J, McLachlan SM, Rapoport B, Estienne V, Ruf J, Chardes T, Peraldi-Roux S: Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. J Biol Chem 2004, 279:39058-67.
41. Gora M, Gardas A, Watson PF, Hobby P, Weetman AP, Sutton BJ, Banga JP: Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis. Biochem Biophys Res Commun 2004, 320:795-801.
42. Bresson D, Rebuffat SA, Nguyen B, Banga JP, Gardas A, Peraldi-Roux S: New insights into the comformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies. Endocrinology 2005 in press.
43. Baker JR, Arscott P, Johnson J: An analysis of the structure and antigenicity of different forms of human thyroid peroxidase. Thyroid 1994, 4:173-8.
44. Jastrzebska-Bohaterewicz E, Gardas A: Proportion of antibodies to the A and B immunodominant regions of thyroid peroxidase in Graves and Hashimoto disease. Autoimmunity 2004, 37:211-6.
45. Jaume JC, Costante G, Nishikawa T, Phillips DI, Rapoport B, McLachlan SM: Thyroid peroxidase autoantibody fingerprints in hypothyroid and euthyroid individuals. I. Cross-sectional study in elderly women. J Clin Endocrinol Metab 1995, 80:994-9.
46. Jaume JC, Kakinuma A, Chazenbalk GD, Rapoport B, McLachlan SM: Thyrotropin receptor autoantibodies in serum are present at much lower levels than thyroid peroxidase autoantibodies: analysis by flow cytometry. J Clin Endocrinol Metab 1997, 82:500-7.